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BACKGROUND         
We have previously described increased serum lactate concentrations in subjects 
with acute asthma exacerbations.  It is not clear if this is due to increased work of 
breathing or a possible side effect of treatment (in particular beta-adrenergic 
agonist therapy).  
 
OBJECTIVES          
1) Determine if a significant correlation exists between treatment lactate or ∆ 
lactate, and serum albuterol concentrations after adjusting for dyspnea score.   
2) Determine if elevated treatment lactate concentrations or ∆ lactate 
concentrations are associated with increased hospital admissions.  
 
METHODS          
•Interim, subgroup analysis of a prospective, interventional, double-blind, placebo 
controlled trial of an IV beta-adrenergic agonist in ED patients with acute asthma 
exacerbations.  
•FEV1 < 50% predicted 30 minutes following initiation of “standard care” (includes 
a minimum of 2.5 mg nebulized albuterol; 0.5 mg nebulized ipratropium; and 50 
mg of a corticosteroid).  ED physicians, unaware of study objectives, administered 
all treatments.   
•Subjects were randomized in a 1:1 ratio to either placebo or  an investigational 
intravenous beta agonist arm.  Blood was obtained at 1 and 1.25 hours after the 
start of the hour long infusion for determination of albuterol , electrolytes, and 
lactate concentrations; and a Modified Borg Dyspnea Score (DS) was calculated 
for all patients.  
•Treatment lactate and ∆ lactate were correlated with 1 hr serum albuterol 
concentrations and hospital admission, using partial Pearson correlations to adjust 
for DS. 
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RESULTS          
•42 subjects were enrolled to date, 20 with complete data.  
 
•The mean baseline serum lactate level was 19.3 mg/dL (SD ±9.5).  This 
increased to 32.6 mg/dL (SD ±15.8) at 1.25 hrs.  
 
•The mean 1 hr DS was 3.85+ 2.0.  
 
•The correlation between treatment lactate, ∆ lactate, 1 hr serum albuterol 
concentrations (R, S and total) and admission to hospital are shown (see table 
below). Both treatment and ∆ lactate were highly correlated with total serum 
albuterol, R albuterol, and S albuterol.  
 
 
 
 
R Albuterol S Albuterol Total Albuterol Admit 
Treatment 
Lactate 
Correlation 
Coefficient 
0.505 0.497 0.674 -0.018 
Significance 
(2 tailed) 
0.028 0.030 0.002 0.910 
Delta 
Lactata 
Correlation 
Coefficient 
0.519 0.525 0.605 -0.075 
Significance 
(2 tailed) 
0.023 0.021 0.006 0.643 
RESULTS (cont.)         
•There was no correlation between treatment lactate or ∆ lactate and hospital 
admission.  There was also no significant difference in mean lactate levels in 
admitted vs. non-admitted  subjects (32.8 mg/dL vs. 32.1 mg/dL, p=0.9).    
•There was a trend in twenty-four hour DS in patients with markedly elevated 
lactate (≥ 30 mg/dL) compared to those with lactate < 30 mg/dL (3.19 vs. 1.88, 
p=0.08) 
 
DISCUSSION         
Lactic acidosis  may be caused by increased production (Type A)  or decreased 
utilization  (metabolism) (Type B). 1  Type B  lactic acidosis may be  caused by 
alcohol or drugs.  There have been several reports of increased lactate associated 
with beta agonists. 2  A  recent study in children  treated for acute severe asthma, 
showed that  the mechanism of lactic acidosis was most often Type B. 3 
 
CONCLUSION         
Lactate and ∆ lactate concentrations correlate with albuterol concentrations in 
patients presenting with acute asthma exacerbations after adjusting for dyspnea 
score, but do not correlate with hospital admission. 
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